Top Markets
Coin of the day
Resverlogix Corp. Resverlogix Corp.

Resverlogix Corp.

RVX
Peringkat dalam Saham #28673
Resverlogix Corporation is a biotechnology firm currently in advanced clinical... Resverlogix Corporation is a biotechnology firm currently in advanced clinical development, concentrating on developing treatments for illnesses where existing medical solutions are inadequate. The company's leading therapeutic compound is apabetalone (RVX-208), a selective small molecule designed to inhibit bromodomain and extra-terminal proteins. This compound is presently undergoing pivotal Phase III clinical trials for patients afflicted with conditions such as cardiovascular disease, diabetes, various stages of kidney disease (including end-stage renal disease), and neurodegenerative disorders. Furthermore, Resverlogix Corp. has forged an alliance with Eversana Life Science Services, LLC to support the forthcoming commercial rollout of apabetalone as a treatment for COVID-19 across the United States and Canada. The company's main office is located in Calgary, Canada.
Harga Saham
$0.07339369
Terakhir disinkronkan: 2026-08-18
Kapitalisasi Pasar
$25.24M
Perubahan (1 hari)
5.26%
Perubahan (1 tahun)
-7.44%
Negara
CA
Perdagangan Resverlogix Corp. (RVX)

Kategori

Riwayat pemecahan saham untuk Resverlogix Corp. (RVX)
Saham Resverlogix Corp. (simbol: RVX) telah mengalami total 0 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Aug 20, 2026.
Satu lembar saham RVX yang dibeli sebelum Aug 20, 2026 sekarang setara dengan 0 lembar saham RVX.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
Tidak cukup data untuk tanggal yang disediakan.
Pemecahan saham untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pemecahan saham Kelipatan Kumulatif Negara
1 x2
US
0 -
US
0 -
NL
1 x3
AU
0 -
CH